Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
about
Novel Insights into the Roles of Rho Kinase in CancerMicroRNAs and benign biliary tract diseasesDeregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential BiomarkersThe microRNA-200 family: small molecules with novel roles in cancer development, progression and therapyBGRMI: A method for inferring gene regulatory networks from time-course gene expression data and its application in breast cancer researchThe real-time dynamic monitoring of microRNA function in cholangiocarcinoma.MicroRNAs in Cholangiopathies.MicroRNA-200b suppresses arsenic-transformed cell migration by targeting protein kinase Cα and Wnt5b-protein kinase Cα positive feedback loop and inhibiting Rac1 activationEmerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma.A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma.Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation.microRNA analysis of gastric cancer patients from Saudi Arabian population.MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1.MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract CancersRelevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.Overexpression of suppressor of zest 12 is associated with cervical node metastasis and unfavorable prognosis in tongue squamous cell carcinoma.Regulation of microRNAs in cancer metastasis.Molecular mechanism of cholangiocarcinoma carcinogenesis.MiRNA-200b Regulates RMP7-Induced Increases in Blood-Tumor Barrier Permeability by Targeting RhoA and ROCKII.microRNA deregulation in keloids: an opportunity for clinical intervention?Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinomaLong noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b.The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA).Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.Deregulated expression of microRNA-200b/c and SUZ12, a Polycomb repressive complex 2 subunit, in chemoresistant colorectal cancer cells.NcRNAs and Cholangiocarcinoma.miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites.In Vivo Phosphoproteome Analysis Reveals Kinome Reprogramming in Hepatocellular Carcinoma.
P2860
Q26771368-E5A1F70B-16EE-491B-87BF-D17A1DA67821Q26865762-9FED1910-D7C5-4E0F-A2DF-EAC6834AB274Q28073195-2219B388-4108-4FAD-ACC3-9F3A810A0C39Q28083742-F4941418-5ACD-4E68-95A7-9F8A197ADE62Q28595423-6AAFC0B0-B5FF-4DCF-BFC1-6C0947DA74FAQ33740551-52FEB0A8-54D6-4396-AE96-023654250BA6Q33991899-DD456700-776E-4F15-9FAF-C6D579EFEB2DQ34073967-257F33A0-3FDC-4EF9-94BB-4C712B2C80CDQ34200081-07360F66-B483-4E9D-ADFD-7303FC8F7F8CQ35562369-29701E16-780A-421C-8600-EB8892F1FDDAQ35921330-2291BC6E-FAFA-4E4E-B89E-385BFF01CBCBQ36170351-B8AB656D-38E5-47B8-91F5-7E4BF8273CA6Q36309379-D2AD1447-BF66-4EC4-A2DE-CBBA4A446D1DQ36319557-A6D4B911-CC7A-4030-AB10-3F5137031781Q36955656-DC842E8F-B630-4D1D-A3FB-D6979159E9CAQ37213574-5A0891D7-FB90-4A84-9F6E-28DEF1818E1FQ37534719-29F86B9E-1A53-4B7A-B389-E2964CA6D242Q37640715-E62C3F07-40CD-4050-AF24-1D312CB78488Q38191102-5ABD28B2-85DC-4488-B0A8-CB49A249934EQ38217475-D4B4CE16-FFFE-4AB2-AD5C-584474F7579BQ38264654-1FC6B296-862D-4501-A21B-F9B1A7A39B1AQ38612431-78717271-4D16-4443-9365-5175F6B44A01Q38740975-D7C413D8-69CA-4E44-A952-D91F983150F3Q38766067-4BF423D5-47DC-4C71-82E0-89907B003404Q39099794-163973EF-E685-4BCF-80D1-85DB36279DFAQ39443955-73167F11-2240-4EA5-BAA1-01350F1C8617Q39630055-DA1937F3-D574-4323-861C-5F637108A9E8Q41659315-CE25723E-BDAE-473E-9026-DDBE3BA005E4Q47153848-EC49AE4E-70FB-4A0B-A2AC-640CE31B81ACQ53099936-56CA861B-1F0F-494C-B166-7D67DD789571Q53708408-D832B6BA-6E1E-4C24-87C6-9020A4FEF9E6Q54124926-88DC2D16-0F7D-4150-BEE7-F4CFB2CAAA62
P2860
Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Direct targeting of SUZ12/ROCK ...... tumourigenesis and metastasis.
@en
Direct targeting of SUZ12/ROCK ...... tumourigenesis and metastasis.
@nl
type
label
Direct targeting of SUZ12/ROCK ...... tumourigenesis and metastasis.
@en
Direct targeting of SUZ12/ROCK ...... tumourigenesis and metastasis.
@nl
prefLabel
Direct targeting of SUZ12/ROCK ...... tumourigenesis and metastasis.
@en
Direct targeting of SUZ12/ROCK ...... tumourigenesis and metastasis.
@nl
P2093
P2860
P356
P1476
Direct targeting of SUZ12/ROCK ...... tumourigenesis and metastasis.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2013.655
P407
P577
2013-10-29T00:00:00Z
P5875
P6179
1008007963